- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02655250
Neonatal Microbiome Validity Study
October 23, 2020 updated by: Amy E. Millen, State University of New York at Buffalo
The Neonatal Microbiome Study: Validity of Biologic Sample Collection Methods
This is a validation study to compare proposed field collection methods with a gold standard collection technique for microbiome analysis of stool and breast milk samples.
Study Overview
Detailed Description
In order to conduct a future study of the gut microbiome in a population living in a rural, low income setting, this validation study will be conducted to verify the validity of our proposed field collection methods for stool and breast milk samples.
We will compare the microbial diversity and abundance in the biologic samples using various proposed field collection methods to an immediately frozen sample.
The proposed field collection methods are feasible for use in a community-based study in a low income setting with limited access to cold storage.
Study Type
Observational
Enrollment (Actual)
5
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Buffalo, New York, United States, 14214
- State University of New York at Buffalo, Farber Hall
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
A convenience sample of men/women willing to provide a stool sample and/or breast milk sample.
Description
Inclusion Criteria:
- Lactating women (for breast milk sample)
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Difference in intestinal microbiome between gold standard and proposed field protocol
Time Frame: Baseline
|
Comparison of microbiome from snap-frozen sample (gold standard) to proposed field collection methods to determine which field method best correlates with the snap-frozen sample.
|
Baseline
|
Difference in breast milk microbiome between gold standard and proposed field protocol
Time Frame: Baseline
|
Comparison of microbiome from snap-frozen sample to proposed field collection methods to determine which field method best correlates with the snap-frozen sample.
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Amy E Millen, PhD, State University of New York at Buffalo
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2015
Primary Completion (Actual)
August 1, 2016
Study Completion (Actual)
December 1, 2017
Study Registration Dates
First Submitted
June 19, 2015
First Submitted That Met QC Criteria
January 11, 2016
First Posted (Estimate)
January 14, 2016
Study Record Updates
Last Update Posted (Actual)
October 27, 2020
Last Update Submitted That Met QC Criteria
October 23, 2020
Last Verified
October 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- 758632-1
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gut Microbiome
-
University of California, DavisCompletedGut Microbiome | Skin Microbiome | Gut Lipidome | Skin Lipidome | Blood LipidomeUnited States
-
ProgenaBiomeRecruitingGastrointestinal Microbiome | Gut MicrobiomeUnited States
-
University College CorkAIT Austrian Institute of Technology GmbHNot yet recruiting
-
Evolve BioSystems, Inc.University of California, DavisCompletedGut MicrobiomeUnited States
-
Access Business GroupCompletedGut MicrobiomeUnited States
-
Washington University School of MedicineCompleted
-
Evolve BioSystems, Inc.Terminated
-
Evolve BioSystems, Inc.CompletedInfant Gut MicrobiomeUnited States
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingGut Microbiome | Linear GrowthUnited States
Clinical Trials on Microbiome
-
Medical University of GrazUniversity of RostockCompletedCongenital Diaphragmatic HerniaAustria
-
Copenhagen University Hospital, HvidovreCompletedTransplantation | Vaginal Dysbiosis | Vaginal MicrobiomeDenmark
-
Hellenic Institute for the Study of SepsisCompletedClostridioides Difficile InfectionGreece
-
Tampere University HospitalActive, not recruitingInfertility, FemaleFinland
-
Instituto Valenciano de Infertilidad, IVI AlicanteCompleted
-
Hospital Universitario de CabuenesMerck Sharp & Dohme LLC; Hospital Universitario Central de Asturias; Instituto...UnknownClostridium Difficile Infection
-
Region SkaneCompletedChronic Rhinosinusitis (Diagnosis)Sweden
-
University of Alabama at BirminghamRecruitingSpinal Cord Injuries | Gut MicrobiomeUnited States
-
Sydney LeibelActive, not recruiting
-
University of PennsylvaniaTerminatedRecurrent Clostridium Difficile InfectionUnited States